Gefitinib and pyrrolidine dithiocarbamate decrease viral replication and cytokine production in dengue virus infected

Anyelo Duran1, Nereida Valero2, Jesús Mosquera3

  • 1Instituto de Investigaciones Clínicas "Dr. Américo Negrette", Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela; Cátedra de Bioquímica General, Escuela de Bioanálisis, Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela; Sociedad Venezolana de Microbiología, Venezuela.

Life Sciences
|October 23, 2017
PubMed
Abstract

Insights

Gefitinib (GBTC) and pyrrolidine dithiocarbamate (PDTC) reduced dengue virus type 2 (DENV2) replication and pro-inflammatory cytokine production in human monocytes. These findings suggest potential therapeutic benefits for dengue treatment by targeting EGFR/NOD2 and NF-kB pathways.

Area of Science:

  • Virology
  • Immunology
  • Pharmacology

Background:

  • Epidermal growth factor receptor (EGFR) and nucleotide-binding and oligomerization-domain containing 2 (NOD2) are implicated in cancer and microbial recognition, respectively.
  • Both EGFR and NOD2 activate NF-kB signaling, leading to inflammatory gene expression.
  • Monocytes are crucial for early dengue virus (DENV) replication and cytokine release.

Purpose of the Study:

  • To investigate the effects of Gefitinib (GBTC), an EGFR inhibitor, and pyrrolidine dithiocarbamate (PDTC), an NF-kB inhibitor, on DENV serotype 2 (DENV2) replication.
  • To assess the impact of GBTC and PDTC on cytokine production in DENV2-infected human monocyte cultures.

Main Methods:

  • Human monocyte cultures were infected with DENV2.
  • Inhibition of EGFR/NOD2 was achieved using GBTC, and NF-kB inhibition using PDTC.
  • Cytokine production was quantified using ELISA, and viral replication was measured by plaque-forming unit (PFU) assays.

Main Results:

  • DENV2 infection led to increased viral replication and the production of antiviral cytokines (IFN-α/β, TNF-α, IL-12, IL-18).
  • Inhibition of EGFR/NOD2 with GBTC or NF-kB with PDTC significantly decreased DENV2 replication.
  • Both GBTC and PDTC treatments reduced the production of pro-inflammatory cytokines in infected monocytes.

Conclusions:

  • GBTC and PDTC demonstrate inhibitory effects on DENV2 replication and associated cytokine production.
  • These findings highlight a potential therapeutic role for targeting EGFR/NOD2 and NF-kB pathways in managing dengue infection.
  • The study suggests that EGFR/NOD2 receptors and NF-kB signaling are involved in the pathogenesis of dengue virus infection.

Related Concept Videos